BOTOX

Botox treatment may restrict emotional growth

 Clinicians came with recent findings that botox treatment in young people may restrict emotional growth. Experts warn that frozen faces stop young people from expressing their emotions fully.

The findings are published in the Journal of Aesthetic Nursing. Group of Plastic Surgeons in US warns of after effects and say injecting teenagers is morally wrong.

Findings say botox treatment will temporarily paralyse upper face muscles which reduces wrinkling when people frown.


Botox may suppressed cancer tumor :study


Researchers found that Botox could block signals from the vagal nerve -- which extends from the brain stem to the abdomen -- slowing the growth of tumors as much as surgery would. 

"We found that by removing the effect of the nerve, the stem cells in the cancer tumor are suppressed, leading to cancer treatment and prevention," said co-author Duan Chen, a professor at the Norwegian University of Science and Technology.

Botox worked when injected locally to the vagus nerve by blocking the release of a neurotransmitter, acetylcholine, that encouraged the tumor to grow. 

Other techniques -- such as surgically cutting the vagus nerve and giving a blocking drug -- also slowed tumor growth. Blocking acetylcholine through facial injections lessens wrinkles by temporarily paralyzing muscles.


Botox pricks can fight cancer of stomach


Scientists have suggested that Botox, the popular wrinkle eraser, could also be effective in treating stomach cancers. Through their study, the scientists have shown how the drug slows cancer growth by eliminating the signals sent by nerves that are linked to cancer stem cells. 

Led by Duan Chen, professor at Norwegian University of Science and Technology, and Timothy Wang, professor at the Columbia University.

The promising results from this study have led to an initiation of a phase II clinical trial for patients with stomach cancer in Norway. Researchers believe the Botox treatment could be an additional treatment for patients who have inoperable stomach cancer, or patients who have received chemotherapy but no longer respond to such therapy.